--- title: "12 Health Care Stocks Moving In Tuesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/296256261.md" description: "During Tuesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included AIxCrypto Hldgs (AIXC) up 132%, Amylyx Pharmaceuticals (AMLX) up 54.45%, and China SXT Pharmaceuticals (SXTC) up 30.13%. Conversely, losers saw DocGo (DCGO) drop 26.7%, ALPS Group (ALPS) fall 16.93%, and BioVie (BIVI) decline 16.24%. Many movements coincided with recent earnings reports." datetime: "2026-08-18T17:05:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296256261.md) - [en](https://longbridge.com/en/news/296256261.md) - [zh-HK](https://longbridge.com/zh-HK/news/296256261.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Intraday Session ### Gainers - **AIxCrypto Hldgs** (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regular session. The market value of their outstanding shares is at $14.3 million. - **Amylyx Pharmaceuticals** (NASDAQ:AMLX) stock increased by 54.45% to $33.1. The company's market cap stands at $2.3 billion. - **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock moved upwards by 30.13% to $4.88. The company's market cap stands at $2.0 million. - **OSR Health** (NASDAQ:OSRH) shares rose 25.52% to $0.74. The market value of their outstanding shares is at $20.7 million. As per the news, the Q2 earnings report came out 2 days ago. - **Modular Medical** (NASDAQ:MODD) shares increased by 25.31% to $2.97. The company's market cap stands at $12.8 million. The company's, Q1 earnings came out 2 days ago. - **Scribe Therapeutics** (NASDAQ:SCTX) shares moved upwards by 25.15% to $26.52. The company's market cap stands at $342.8 million. ### Losers - **DocGo** (NASDAQ:DCGO) stock decreased by 26.7% to $0.52 during Tuesday's regular session. The market value of their outstanding shares is at $70.1 million. As per the press release, Q2 earnings came out yesterday. - **ALPS Group** (NASDAQ:ALPS) stock decreased by 16.93% to $0.27. The company's market cap stands at $53.2 million. - **BioVie** (NASDAQ:BIVI) shares declined by 16.24% to $0.98. The market value of their outstanding shares is at $8.8 million. As per the news, the Q4 earnings report came out 3 days ago. - **Jasper Therapeutics** (NASDAQ:JSPR) stock decreased by 12.61% to $0.74. The market value of their outstanding shares is at $28.0 million. As per the press release, Q2 earnings came out 2 days ago. - **NextCure** (NASDAQ:NXTC) stock decreased by 12.52% to $6.75. The company's market cap stands at $35.2 million. - **Valion Bio** (NASDAQ:VBIO) shares decreased by 12.11% to $0.16. The company's, Q2 earnings came out 2 days ago. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md) - [ALPS.US](https://longbridge.com/en/quote/ALPS.US.md) - [AIXC.US](https://longbridge.com/en/quote/AIXC.US.md) - [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md) - [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md) - [DCGO.US](https://longbridge.com/en/quote/DCGO.US.md) - [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md) - [MODD.US](https://longbridge.com/en/quote/MODD.US.md) - [SCTX.US](https://longbridge.com/en/quote/SCTX.US.md) - [JSPR.US](https://longbridge.com/en/quote/JSPR.US.md) - [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md) - [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md) - [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md) - [ALPWF.US](https://longbridge.com/en/quote/ALPWF.US.md) - [BIVIW.US](https://longbridge.com/en/quote/BIVIW.US.md) ## Related News & Research - [DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference | DCGO Stock News](https://longbridge.com/en/news/297645979.md) - [AIxCrypto RoboShare completes first paid commercial robot-sharing deployment in Malibu](https://longbridge.com/en/news/297513808.md) - [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md) - [BioVie completes treatment phase of Phase 2 Long COVID trial for bezisterim](https://longbridge.com/en/news/297513911.md) - [BioVie President and CEO Cuong V Do acquires 15,210 shares worth $31,637.68](https://longbridge.com/en/news/297376996.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**